PTGX
Protagonist Therapeutics (PTGX) Earnings
Review Protagonist Therapeutics (PTGX) earnings with server-rendered company data, supporting context and links to related investor research.
- Annual EPS
- -2.05
- Trailing EPS
- 1.03
- Annual revenue
- $46.02M
- Trailing revenue
- $282.00M
- Next earnings date
- 2026-08-18
- Earnings data source
- MarketBeat historical revenue consensus + S&P Global consensus via StockAnalysis
Protagonist Therapeutics (PTGX) Earnings research
The PTGX earnings page organizes the available earnings-per-share and revenue context for Protagonist Therapeutics. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.